The Effect of Muscarinic Receptor Modulators on the Antinociception Induced by CB2 Receptor Agonist, JWH133 in Mice

被引:1
|
作者
Alipour, M. [1 ]
Fekrmandi, F. [2 ]
Onsori, S. [1 ]
Tabrizian, P. [1 ]
Jafari, M. R. [1 ]
机构
[1] Zanjan Univ Med Sci, Sch Med, Dept Physiol & Pharmacol, Zanjan 45147, Iran
[2] McGill Univ, Dept Med, Montreal, PQ, Canada
关键词
antinociception; JWH-133; pilocarpine; atropine; formalin test; mice;
D O I
10.1055/s-0042-112365
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
There is no published study regarding the interaction between muscarinic receptor modulators and antinociception induced by cannabinoid receptor (CB2) agonist. The effect of pilocarpine (a muscarinic agonist) and atropine (a muscarinic antagonist) on JWH-133 (a CB2 agonist) induced analgesia in mice was studied. First the analgesic effect of JWH-133 (0.001-1mg/Kg) or pilocarpine (2.5-20mg/kg) or atropine (0.2-5mg/kg) was evaluated. Subsequently, the effect of co-administration of pilocarpine (2.5mg/kg) or atropine (5mg/kg) and JWH-133 (0.001-1mg/Kg) were studied too. JWH-133 and pilocarpine provoked antinociception in mice but atropine did not. Pilocarpine potentiated the analgesic effect of JWH-133 but atropine antagonized that. It can be concluded that JWH-133 induced antinociception is affected by muscarinic receptor modulators in mice.
引用
收藏
页码:597 / 602
页数:6
相关论文
共 50 条
  • [21] Effect of CB2 receptor deletion in streptozotocin-induced diabetic mice
    Barutta, F.
    Corbelli, A.
    Pinach, S.
    Rastaldi, M. P.
    Perin, P. Cavallo
    Gruden, G.
    DIABETOLOGIA, 2011, 54 : S45 - S45
  • [22] CB2 cannabinoid receptor-mediated peripheral antinociception
    Malan, TP
    Ibrahim, MM
    Deng, HF
    Liu, Q
    Mata, HP
    Vanderah, T
    Porreca, F
    Makriyannis, A
    PAIN, 2001, 93 (03) : 239 - 245
  • [23] TREATMENT WITH CB2 AGONIST JWH-133 REDUCES OXIDATIVE STRESS AND FIBROSIS IN PENIS FROM APOE-/- MICE
    Fraga-Silva, R. A.
    Costa-Fraga, F. P.
    Savergnini, S. Q.
    Montecucco, F.
    Mach, F.
    Steffens, S.
    Stergiopulos, N.
    Santos, R. A. S.
    da Silva, R. F.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 228 - 229
  • [24] JWH-133, a Selective Cannabinoid CB2 Receptor Agonist, Exerts Toxic Effects on Neuroblastoma SH-SY5Y Cells
    Jakub Wojcieszak
    Wojciech Krzemień
    Jolanta B. Zawilska
    Journal of Molecular Neuroscience, 2016, 58 : 441 - 445
  • [25] JWH-133, a Selective Cannabinoid CB2 Receptor Agonist, Exerts Toxic Effects on Neuroblastoma SH-SY5Y Cells
    Wojcieszak, Jakub
    Krzemien, Wojciech
    Zawilska, Jolanta B.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2016, 58 (04) : 441 - 445
  • [26] Activation of Cannabinoid Type 2 Receptor by JWH133 Protects Heart Against Ischemia/Reperfusion-Induced Apoptosis
    Li, Qian
    Wang, Feng
    Zhang, Yan-Min
    Zhou, Jing-Jing
    Zhang, Yi
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2013, 31 (4-5) : 693 - 702
  • [27] Activation of the Cannabinoid Receptor 2 by JWH133 attenuates neurological deficits and brain edema after experimental intracerebral hemorrhage in mice
    Iniaghe, Loretta Oghenekome
    Burchell, Sherrefa R.
    Zhang, John H.
    Tang, Jiping
    FASEB JOURNAL, 2016, 30
  • [28] Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice
    M. Salaga
    H. Zatorski
    M. Zielińska
    P. Mosinska
    J-P. Timmermans
    R. Kordek
    M. Storr
    J. Fichna
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2017, 390 : 1015 - 1027
  • [29] Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice
    Salaga, M.
    Zatorski, H.
    Zielinska, M.
    Mosinska, P.
    Timmermans, J-P.
    Kordek, R.
    Storr, M.
    Fichna, J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 (10) : 1015 - 1027
  • [30] Immunoregulation of a CB2 Receptor Agonist in a Murine Model of NeuroAIDS
    Santhi Gorantla
    Edward Makarov
    Deepa Roy
    Jennifer Finke-Dwyer
    L. Charles Murrin
    Howard E. Gendelman
    Larisa Poluektova
    Journal of Neuroimmune Pharmacology, 2010, 5 : 456 - 468